Pharmacoequity & Biologics In The Allergy Clinic: Providing The Right Care, At The Right Time, Every time, To Everyone

AE Conway, J Lieberman, CD Codispoti… - The Journal of Allergy …, 2024 - Elsevier
Pharmacoequity refers to equity in access to pharmacotherapy for all patients and is an
especially large barrier to biologic agents in patients with allergic diseases. Value-based …

Growing up with allergies: transitioning from adolescence to adulthood

AP Huntley, M Verdi, AE Conway, H Sharma… - Annals of Allergy …, 2023 - Elsevier
Allergic disease management for adolescents and young adults requires consideration of
unique psychosocial challenges and opportunities. Erik Erikson's model for the Stages of …

Inhaled epinephrine for anaphylaxis: Time for another look?

MS Shaker, DBK Golden… - Annals of allergy …, 2024 - pubmed.ncbi.nlm.nih.gov
Inhaled epinephrine for anaphylaxis: Time for another look? Inhaled epinephrine for
anaphylaxis: Time for another look? Ann Allergy Asthma Immunol. 2024 Mar;132(3):267-269 …

Balancing benefits and potential harms of stock inhaler policies in schools

AE Conway, M Verdi, J Oppenheimer… - Annals of Allergy …, 2024 - annallergy.org
In this issue of Annals of Allergy, Asthma & Immunology, Hardy et al 1 provide valuable
insights into the feasibility and acceptability of common canister policies in schools. Schools …

[引用][C] Primatene mist: Does it have a place in treating croup?

DR Liptzin - Annals of Allergy, Asthma & Immunology, 2024 - annallergy.org
To the Editor,—I read with interest the article by Ho et al, 1 “Costeffectiveness of budesonide-
formoterol vs inhaled epinephrine in US adults with mild asthma.” How interesting to see a …